IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
企業コードIRMD
会社名IRadimed Corp
上場日Jul 16, 2014
最高経営責任者「CEO」Mr. Roger Susi
従業員数160
証券種類Ordinary Share
決算期末Jul 16
本社所在地1025 Willa Springs Dr.
都市WINTER SPRINGS
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号32708
電話番号14076778022
ウェブサイトhttps://www.iradimed.com/
企業コードIRMD
上場日Jul 16, 2014
最高経営責任者「CEO」Mr. Roger Susi
過去5年間の配当金総支払額は
39.46M
米ドルである。
IRMD.NB Interim Cash Dividend of gross USD 0.17 paid on Mar 05, 2025 going ex on Feb 24, 2025
IRMD.NB Final Cash Dividend of gross USD 0.15 paid on Nov 25, 2024 going ex on Nov 15, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on Aug 30, 2024 going ex on Aug 20, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on May 30, 2024 going ex on May 17, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on Jan 12, 2024 going ex on Dec 21, 2023